Standard BioTools Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-60.5M | $-76.0M | $-53.3M | $-52.8M | $-16.5M | $-19.0M | $-22.5M | $-16.9M |
| Depreciation & Amortization | $7.4M | $6.7M | $4.9M | $4.1M | $2.6M | $2.2M | $1.4M | $1.1M |
| Depreciation | $5.9M | $5.1M | $3.6M | $3.0M | — | — | — | — |
| Amortization | $11.2M | $11.2M | $11.2M | $9.8M | $0 | $0 | $300.0K | — |
| Stock-Based Compensation | $9.1M | $13.9M | $16.8M | $20.9M | $6.4M | $4.1M | $2.8M | $1.6M |
| Net Cash from Operating Activities | $-24.1M | $-39.1M | $-34.7M | $-22.6M | $-1.6M | $-17.5M | $-17.5M | $-11.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.6M | $5.1M | $4.0M | $7.4M | $3.4M | $2.4M | $1.7M | $1.5M |
| Business Acquisitions | — | $0 | $0 | $113.2M | $0 | $0 | — | — |
| Net Cash from Investing Activities | $17.7M | $45.1M | $25.7M | $-178.4M | $-27.6M | $14.0M | $-45.1M | $-1.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $29.0M | $116.0K | $5.3M | $200.3M | $5.8M | $48.5M | $70.4M | $3.8M |
| Net Change in Cash | $23.0M | $5.9M | $-4.6M | $-1.5M | $-23.4M | $45.1M | $7.8M | $-8.9M |
| Free Cash Flow | $-25.7M | $-44.2M | $-38.7M | $-30.0M | $-5.0M | $-19.9M | $-19.2M | $-13.0M |